Waters Corporation stock hits 52-week high at 420.3 USD
Waters Corporation (WAT) stock reached a new 52-week high of $420.3, reflecting a robust 44.4% appreciation over the last year. Despite strong recent returns and exceeding Q2 2026 earnings expectations, InvestingPro Tips suggest the stock may be overvalued. TD Cowen upgraded the stock to Buy with a $475 price target, anticipating continued high-single-digit growth.
Waters Corporation stock hits 52-week high at 420.3 USD By Investing.com
Waters Corporation (WAT) stock recently reached a 52-week high of $420.3, reflecting a robust 44.4% appreciation over the past year. Despite this strong performance and exceeding Q2 2026 earnings and revenue expectations, InvestingPro Tips suggest the stock might be overvalued. The company also received an upgrade to "Buy" from TD Cowen with a $475 price target, highlighting its strategic outlook amidst market conditions.
Waters stock climbs after earnings beat and guidance lift
Waters Corp (US9418481035) stock climbed to $416.45 after reporting a second-quarter beat with revenue of $1.65 billion and adjusted EPS of $3.05, exceeding expectations. The company also lifted its 2026 adjusted EPS guidance to $14.45-$14.65 and organic growth to 7%-9%. Analyst consensus remains a Moderate Buy with a price target of $420.35, placing importance on the execution of the new guidance.
Thermo Fisher Scientific (TMO) Climbed, So What Is Behind The Fresh Attention?
Thermo Fisher Scientific (TMO) has seen increased attention after exceeding analyst expectations with its latest quarterly revenue and earnings, and completing a Parkinson's proteomics project. This strong performance has led to a 16.6% share price return over the past 30 days and a 24.5% total shareholder return over the past year. While some valuations suggest the stock is slightly overvalued, a Discounted Cash Flow model by Simply Wall St indicates it might be modestly undervalued, prompting investors to consider both the optimistic outlook and potential risks.
Edmond DE Rothschild Holding S.A. Acquires New Shares in Waters Corporation $WAT
Edmond DE Rothschild Holding S.A. has acquired a new stake of 22,619 shares in Waters Corporation (NYSE:WAT), valued at approximately $8.48 million, during the second quarter. Other institutional investors have also adjusted their positions in Waters, which has seen its stock rise by 3.8%. The company recently reported strong earnings, beating consensus estimates, and analysts have issued a "Moderate Buy" rating with an average target price of $420.35.
Deutsche Bank AG Takes $156.34 Million Position in Waters Corporation $WAT
Deutsche Bank AG has acquired a new stake of 416,850 shares in Waters Corporation (NYSE:WAT), valued at approximately $156.34 million, making it a 0.42% owner of the company. Other institutional investors have also adjusted their holdings, while a director recently sold a significant number of shares. Waters Corporation has received a "Moderate Buy" rating from analysts with an average price target of $420.35, following a strong Q2 2026 earnings beat and positive revenue growth.
Agilent Technologies (A) Gains Attention In Cannabis Testing, Is It Fully Valued?
Agilent Technologies (A) is gaining attention due to its role as a key supplier in the expanding cannabis testing services market, with recent share price gains of 19.31% in one month and 35.39% in 90 days. Despite a narrative suggesting it's 3.5% undervalued with a fair value of $161 based on recurring revenue and margin expansion, its current P/E ratio of 31x exceeds the fair ratio of 24x. Investors are encouraged to review the full picture, considering both growth prospects and risks like higher tariffs and tighter research funding.
Waters Corp. stock underperforms Wednesday when compared to competitors despite daily gains
Waters Corp. (WAT) shares rose 3.64% on Wednesday, outperforming the broader market indexes like the S&P 500 and Dow Jones Industrial Average. Despite this daily gain, the stock underperformed when compared to its competitors. This increase broke a four-day losing streak for the company's shares.
Waters stock slips after earnings beat and guidance holds
Waters Corp (WAT) stock experienced a slight dip despite beating earnings expectations for the latest quarter, reporting $1.65 billion in revenue and $3.05 EPS against an expected $1.62 billion and $3.01 respectively. The company also issued Q3 and FY 2026 EPS guidance, which, while competitive, did not prevent the stock from trading lower. The market's focus remains on whether Waters can sustain growth and improve its narrow profitability margins, especially given its high P/E ratio.
239,613 Shares in Waters Corporation $WAT Bought by Mitsubishi UFJ Asset Management Co. Ltd.
Mitsubishi UFJ Asset Management Co. Ltd. recently acquired a new stake in Waters Corporation (NYSE:WAT), purchasing 239,613 shares valued at approximately $89.86 million during the second quarter. This move makes Mitsubishi UFJ Asset Management Co. Ltd. one of several institutional investors holding Waters stock, with institutions collectively owning 94.01% of the company. The article also details recent insider selling, analyst ratings, and the company's financial performance, including its latest earnings report where it beat consensus estimates.
How Investors May Respond To Thermo Fisher Scientific (TMO) Expanding Access To Parkinson’s Proteomic Data
Thermo Fisher Scientific (TMO) has completed large-scale Olink Explore HT proteomic analysis on Parkinson's samples from The Michael J. Fox Foundation, making the data accessible for research. This initiative reinforces Thermo Fisher's role in precision medicine and its focus on innovation and recurring revenue. Investors should consider how this strengthens the company's long-term strategy, even as concerns about China exposure and margin pressure in Analytical Instruments persist.
Waters Corp. stock underperforms Tuesday when compared to competitors
Waters Corp. (WAT) shares fell 1.59% on Tuesday, closing at $401.25, while the broader market indices, the S&P 500 and Dow Jones Industrial Average, also experienced declines. This marks the fourth consecutive day of losses for Waters Corp. stock, indicating an underperformance compared to its competitors and the overall market.
Revvity (RVTY) Could Be 4% Undervalued After SuperFlex Launch And Q2 Update
Revvity (RVTY) has launched its SuperFlex prenatal screening system and released its Q2 earnings, showing strong recent stock momentum. While a valuation narrative suggests the stock is about 4% undervalued at $121.07 compared to its last close, its current P/E ratio of 54.6x is significantly higher than industry averages, indicating potential valuation risk. Investors are advised to review the company's fundamentals and risks carefully.
Waters stock holds above $410 as guidance and valuation draw attention
Waters Corporation stock is trading above $410 per share, with management reiterating Q3 2026 EPS guidance of $3.95-$4.05 and full-year EPS guidance of $14.45-$14.65. Despite a "moderate buy" analyst consensus, the company's valuation, at 8.7 times price-to-sales, significantly exceeds the life sciences industry average of 4.1 times and its peer group average of 5.3 times, highlighting investor confidence in its chromatography and mass spectrometry technologies. The premium valuation is attributed to Waters' steady demand in regulated end markets and strong operating margins.
Waters Corp. stock underperforms Monday when compared to competitors
Waters Corp. (WAT) stock fell 1.07% on Monday, closing at $407.74. This underperformance occurred during a generally poor trading session where both the S&P 500 and Dow Jones Industrial Average also declined. This marked the third consecutive day of losses for Waters Corp. stock.
AKO CAPITAL LLP's Waters Corp(WAT) Holding History
This article details AKO CAPITAL LLP's investment history in Waters Corp (WAT) as of June 30, 2026. AKO CAPITAL LLP holds 203,356 shares valued at $76.27 million, representing 1.78% of their portfolio. The firm has made 8 purchases and 4 sales of WAT shares since 2023Q3, resulting in an estimated gain of $62.96 million.
Levin Capital Strategies L.P. Sells 3,015 Shares of Waters Corporation $WAT
Levin Capital Strategies L.P. reduced its stake in Waters Corporation (NYSE:WAT) by 10.2% in the second quarter, selling 3,015 shares and holding 26,520 shares valued at $9.95 million. This divestment comes amidst significant institutional investment activity in Waters, with several other large investors increasing their holdings, and mixed analyst ratings. Waters Corporation recently reported strong Q2 earnings, exceeding analyst estimates, and provided positive guidance for Q3 and FY 2026.
Milford Funds Ltd. Acquires 68,768 Shares of Waters Corporation $WAT
Milford Funds Ltd. significantly increased its stake in Waters Corporation (NYSE:WAT) by 103.1% in the second quarter, purchasing an additional 68,768 shares. The firm now holds 135,437 shares valued at $50,794,000. Institutional investors collectively own 94.01% of Waters Corporation's stock, while company insiders own 0.31%.
Sumitomo Mitsui Trust Group Inc. Sells 9,179 Shares of Waters Corporation $WAT
Sumitomo Mitsui Trust Group Inc. reduced its stake in Waters Corporation (NYSE:WAT) by 4.1% during the second quarter, selling 9,179 shares and retaining 214,145 shares valued at approximately $80.3 million. Despite this sale, institutional investors collectively own 94.01% of the company. Waters Corporation has received a consensus "Moderate Buy" rating from analysts, with several firms raising their price targets after the company exceeded quarterly earnings and revenue expectations.
Daiwa Securities Group Inc. Cuts Holdings in Waters Corporation $WAT
Daiwa Securities Group Inc. reduced its stake in Waters Corporation by 18.5% in Q2, selling 4,908 shares and retaining 21,686 shares worth $8.1 million. Waters Corporation exceeded Q2 earnings and revenue expectations, reporting $3.05 adjusted EPS and $1.65 billion in revenue. Analyst sentiment remains positive, with a "Moderate Buy" consensus rating and an average price target of $420.35, with some firms raising their targets.
Assetmark Inc. Has $1.57 Million Stake in Waters Corporation $WAT
Assetmark Inc. significantly reduced its stake in Waters Corporation (NYSE:WAT) by 56.5% in the second quarter, now holding 4,196 shares valued at $1.57 million. Other institutional investors like Zions Bancorporation and SHP Wealth Management have recently adjusted their positions in Waters, with institutional ownership standing at 94.01%. Insider activity also includes Director Christopher A. Kuebler selling 3,626 shares for over $1.4 million.
Aberdeen Group plc Acquires 12,570 Shares of Waters Corporation $WAT
Aberdeen Group plc increased its stake in Waters Corporation by 10% in the second quarter, purchasing an additional 12,570 shares to bring its total holdings to 138,104 shares valued at $51.8 million. Waters Corporation reported strong quarterly earnings, exceeding analyst expectations with adjusted EPS of $3.05 and revenue of $1.65 billion. Analysts maintain a "Moderate Buy" rating for Waters, with an average price target of $420.35, and the company has issued positive fiscal 2026 EPS guidance.
Agilent (A) Stock Looks Below Fair Value But Above Fair Value On Earnings
Agilent Technologies (A) stock shows a mixed valuation, with its Discounted Cash Flow (DCF) model suggesting it is undervalued by 16.8%, indicating potential upside. However, its P/E ratio of 29.7x, while below the industry average, is above its modeled fair P/E of 24.1x, suggesting it is overvalued based on earnings. The article concludes that the stock's future movement depends on whether investors prioritize its long-term cash generation potential or current earnings multiples.
iA Global Asset Management Inc. Raises Stake in Waters Corporation $WAT
iA Global Asset Management Inc. significantly increased its stake in Waters Corporation ($WAT) by 825.1% in the second quarter, bringing its total holdings to 16,097 shares valued at approximately $6.04 million. Other institutional investors also adjusted their positions, with institutional investors and hedge funds now owning 94.01% of the company's stock. Waters recently exceeded quarterly earnings expectations and provided strong fiscal 2026 EPS guidance, while analysts maintain a "Moderate Buy" consensus for the stock.
Erste Asset Management GmbH Sells 3,078 Shares of Waters Corporation $WAT
Erste Asset Management GmbH reduced its stake in Waters Corporation by 27.1% in the second quarter, selling 3,078 shares and retaining 8,268 shares valued at $3.07 million. Waters Corporation exceeded quarterly expectations with $3.05 EPS and $1.65 billion in revenue, representing a 113.3% year-over-year revenue increase. The company maintains a "Moderate Buy" consensus rating from analysts with an average price target of $420.35, and it has provided strong guidance for Q3 and full-year 2026 EPS.
Becton Dickinson EVP Roland Goette sells $440,887 in stock
Roland Goette, EVP at Becton Dickinson & Co (NYSE:BDX), sold 2,438 shares of company stock for $440,887 on August 11, 2026. Despite this insider sale, InvestingPro analysis suggests the stock is undervalued with potential upside. The transaction follows Becton Dickinson's strong Q3 fiscal 2026 results, which surpassed Wall Street expectations for earnings and revenue.
Becton Dickinson EVP Roland Goette sells $440,887 in stock
Roland Goette, EVP at Becton Dickinson & Co (NYSE:BDX), sold 2,438 shares of company stock for $440,887 on August 11, 2026. Despite the insider sale, InvestingPro analysis suggests the stock is undervalued with potential upside. This transaction follows Becton Dickinson's strong third-quarter fiscal 2026 results, where the company surpassed Wall Street expectations for earnings and revenue and raised its full-year outlook.
Waters Corporation (NYSE: WAT) swings to Q2 loss after $13B BDS acquisition
Waters Corporation reported a significant Q2 2026 net loss of $136 million, swinging from a net income of $147 million in the prior year, following its $12.96 billion acquisition of BD’s Biosciences and Diagnostic Solutions (BDS) business. Despite revenues more than doubling to $1.65 billion due to the acquisition, the loss was driven by substantial integration-related costs, including $244 million in purchased intangibles amortization, $49 million in restructuring charges, and increased interest expenses. The company also undertook a 3% workforce reduction to manage costs post-acquisition.
Handelsbanken Fonder AB Acquires 45,145 Shares of Waters Corporation $WAT
Handelsbanken Fonder AB significantly increased its stake in Waters Corporation (NYSE:WAT) by 93.1% in the second quarter, acquiring an additional 45,145 shares. This brought their total holdings to 93,653 shares, valued at $35.12 million. The article also details recent activities by other institutional investors, insider stock sales, Waters' financial performance, and current analyst ratings, which largely suggest a "Moderate Buy" consensus for the stock.
WATERS CORP /DE/ 2Q 2026: Revenue $1.65B, EPS $(1.39) — 10-Q Summary
Waters Corp (WAT) reported its second-quarter 2026 results, showing a significant increase in revenue to $1.65 billion, primarily due to the acquisition of BDS. Despite the revenue growth, the company posted a net loss of $136 million and diluted earnings per share of $(1.39) for the quarter. Business highlights include strong recurring and consumables momentum, broad geographic expansion, and ongoing operational integration efforts including a workforce reduction.
Waters Corporation stock hits 52-week high at $414.15
Waters Corporation (WAT) stock reached a new 52-week high of $414.15, marking a 47.43% increase over the past year and a 25% gain in the last six months. Despite trading at a high P/E ratio of 185.8 and being considered overvalued by InvestingPro analysis, the company recently surpassed Q2 2026 earnings and revenue expectations. Additionally, TD Cowen upgraded Waters' stock to "Buy" with a raised price target of $475, citing expectations for continued high-single-digit growth.
Dynamic Advisor Solutions LLC Sells 8,431 Shares of Waters Corporation $WAT
Dynamic Advisor Solutions LLC significantly reduced its stake in Waters Corporation (NYSE:WAT) by 85.3% in the second quarter of 2026, selling 8,431 shares and retaining 1,450 shares valued at $544,000. Waters Corporation recently reported strong quarterly earnings, beating analyst expectations with an EPS of $3.05 and revenue of $1.65 billion, and provided optimistic guidance for the third quarter and full year 2026. Analysts maintain a "Moderate Buy" consensus rating for Waters, with an average target price of $418.10.
Revvity (RVTY) Lifted Its Outlook, Is The Stock Fully Priced?
Revvity (RVTY) recently released its Q2 2026 results and declared a dividend, leading to a lifted outlook. The stock has seen positive short-term momentum, but its valuation is split, with a fair value estimate suggesting it's undervalued at $121.07, while its P/E ratio of 54.5x is above the industry average, indicating a rich price.
Dudley & Shanley Inc. Has $8.85 Million Stake in Waters Corporation $WAT
Dudley & Shanley Inc. significantly increased its stake in Waters Corporation (NYSE:WAT) by 101.3% in the second quarter, now holding 23,590 shares valued at $8.85 million. Institutional investors collectively own 94.01% of Waters' stock, which recently exceeded quarterly expectations with $3.05 EPS and $1.65 billion in revenue. Analysts generally maintain a "Moderate Buy" rating, with an average price target of $418.10, and some firms raising their targets.
Waters Corporation (NYSE:WAT) Given Average Recommendation of "Moderate Buy" by Analysts
Waters Corporation (NYSE:WAT) has received a "Moderate Buy" consensus rating from twenty analysts, with an average 12-month price target of $418.10. The company recently surpassed quarterly earnings and revenue expectations, reporting $3.05 in adjusted EPS and $1.65 billion in revenue. Shares are currently trading near their 52-week high, and institutional investors hold a significant 94.01% stake in the company.
Santana Row remakes retail space into office
Santana Row in San Jose is converting former retail space, specifically a second-floor area previously occupied by H&M, into office space for Veeam Software. This move is driven by the demand for office space due to the AI boom and Veeam's need for more local employee accommodation, especially after acquiring Securiti.ai. Despite high office vacancy rates in the broader San Jose area, Santana Row's mixed-use appeal has led to 100% office occupancy and increased interest in residential development.
Waters Corp. stock outperforms competitors on strong trading day
Shares of Waters Corp. (WAT) increased by 1.21% to $411.77 on Monday, despite an overall downturn in the stock market where the S&P 500 Index and Dow Jones Industrial Average both saw slight declines. This marked the second consecutive day of gains for Waters Corp.
Jacobs & Co. CA Raises Position in Waters Corporation $WAT
Jacobs & Co. CA increased its stake in Waters Corporation (NYSE:WAT) by 22.6% in the second quarter, bringing its total holdings to 15,518 shares valued at $5.8 million. Waters reported strong Q2 earnings and revenue, exceeding analyst estimates, and maintained its full-year EPS guidance. Despite a high P/E ratio and a director's share sale, analyst sentiment remains positive with a "Moderate Buy" rating and an average price target of $418.10, indicating continued institutional support for the company.
Assenagon Asset Management S.A. Raises Position in Waters Corporation $WAT
Assenagon Asset Management S.A. increased its holdings in Waters Corporation (NYSE:WAT) by 19.1% in the second quarter, bringing its total to 130,109 shares valued at $48.8 million. This increase follows Waters Corporation exceeding Q2 earnings and revenue expectations, reporting $3.05 adjusted EPS and $1.65 billion in revenue. Despite positive analyst sentiment and strong institutional ownership, the stock trades near its 52-week high with a high P/E ratio, and a director recently sold a significant number of shares.
Avity Investment Management Inc. Sells 8,625 Shares of Waters Corporation $WAT
Avity Investment Management Inc. significantly reduced its stake in Waters Corporation (NYSE:WAT) by 75.4% in the second quarter, selling 8,625 shares and retaining 2,816 shares valued at $1.06 million. Despite this, Waters exceeded quarterly expectations with adjusted earnings of $3.05 per share and revenue of $1.65 billion, and maintained its full-year 2026 earnings guidance. Analyst sentiment remains positive, with a "Moderate Buy" consensus rating and an average price target of $418.10, although the stock's high P/E ratio suggests a premium valuation.
Labcorp Holdings Inc. (LH) stock price, news, quote and history
This article provides a detailed financial overview of Labcorp Holdings Inc. (LH), including its current stock price, recent news like a dividend announcement, and comprehensive financial data. It covers key metrics such as market capitalization, P/E ratio, earnings, revenue, analyst ratings, and historical performance compared to the S&P 500. The company's business segments, services, and strategic collaborations are also highlighted.
Waters Corp director sells $1.44 million in stock
A director at Waters Corp (NASDAQ:WAT), Christopher A. Kuebler, sold 3,626 shares of the company's common stock for $1.44 million. This transaction occurred after he acquired the same number of shares through the exercise of stock options. Following these transactions, Kuebler directly holds 17,808 shares.
Waters Corp director sells $1.44 million in stock By Investing.com
A director at Waters Corp, Christopher A. Kuebler, sold 3,626 shares of company stock for $1.44 million after exercising stock options. Following the transaction, Kuebler directly holds 17,808 shares. The sale occurred as Waters Corp shares are trading near their 52-week high, and the company recently reported strong Q2 2026 earnings that surpassed analyst expectations.
Waters Corp director sells $1.44 million in stock
Waters Corp director Christopher A. Kuebler sold 3,626 shares of company stock for $1.44 million after exercising stock options. This transaction increased his direct holdings to 17,808 shares. The sale occurred as Waters Corp shares traded near a 52-week high, with the company recently reporting strong Q2 2026 earnings and receiving an analyst upgrade.
Waters Corp (NYSE: WAT) director sells 3,626 shares after option exercise
Waters Corp director Christopher A. Kuebler exercised stock options for 3,626 shares at $136.43 per share on August 6, 2026. On the same day, he sold all 3,626 common shares at $397.94 per share in an open market transaction. This transaction resulted in approximately $948K pre-tax spread and left him with 17,808 direct common shares and zero stock options.
Waters Corp. stock underperforms Friday when compared to competitors despite daily gains
Waters Corp. (WAT) shares advanced 1.79% on Friday, closing at $406.86, despite underperforming its competitors. The company's stock finished 1.76% below its 52-week high of $414.15. The broader market also saw gains, with the S&P 500 Index rising 0.62% and the Dow Jones Industrial Average rising 0.28%.
WATERS CORP. : WELLS FARGO RAISES TARGET PRICE TO $400 FROM $370
Wells Fargo has increased its target price for Waters Corp. (WATERS CORP.) shares to $400 from $370. This update indicates a more optimistic outlook from the financial institution regarding the company's future stock performance.
Waters Corp (WAZ.DU) Analyst insights, Price targets and Recommendations
This article provides analyst insights, price targets, and recommendations for Waters Corp (WAZ.DU), highlighting recent upgrades and downgrades from various financial institutions. It shows that TD Cowen upgraded the stock from Hold to Buy, while other firms like RBC Capital, Evercore ISI Group, Wells Fargo, Barclays, and Goldman Sachs maintained their previous ratings. The stock's current price and daily change are also presented.
[10-Q] BECTON DICKINSON & CO Quarterly Earnings Report
Becton, Dickinson and Company (BDX) has filed its quarterly earnings report (Form 10-Q) for the period ended June 30, 2026. Key highlights include the completion of the spin-off of its former Biosciences and Diagnostic Solutions business and its combination with Waters Corporation, generating a $4 billion cash distribution used for share repurchases and debt repayment. The company reported worldwide revenues of $4.983 billion for the quarter, a 5.4% increase from the prior-year period, driven by strong performance in its Medical Essentials, Connected Care, BioPharma Systems, and Interventional segments. However, the company continues to address unresolved FDA Warning Letters for its El Paso manufacturing facility and Dispensing quality management system, which could impact operations and liabilities.
Becton, Dickinson and Company (BDX) Q3 2026 Earnings Call Transcript
Becton, Dickinson and Company (BDX) reported a strong Q3 2026, with revenue up 4.4% to $5 billion and adjusted EPS of $3.23, exceeding expectations. The company highlighted broad-based growth driven by key growth platforms like biologic drug delivery and advanced patient monitoring, alongside strong operational execution. BDX updated its full-year guidance, expecting revenue growth towards the high end of its low single-digit range and raising its adjusted EPS midpoint, while also discussing strategic pillars of Compete, Innovate, and Deliver for long-term growth.
